Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo targets Hard-to-Treat multiple myeloma

NCT ID NCT05927571

Recruiting now Disease control Sponsor: Genentech, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times

Summary

This early-stage trial is testing a combination of two experimental drugs, cevostamab and elranatamab, in people with multiple myeloma that has returned or stopped responding to prior therapies. The main goals are to check the safety of the combination and find the best dose for future studies. About 120 participants will take part in this open-label study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Center.

    RECRUITING

    Seoul, 05505, South Korea

  • Calvary Mater Newcastle

    RECRUITING

    Waratah, New South Wales, 2298, Australia

  • Hadassah University Hospital - Ein Kerem

    RECRUITING

    Jerusalem, 9112001, Israel

  • Rambam Health Care Campus

    RECRUITING

    Haifa, 3109600, Israel

  • Royal Adelaide Hospital;Haematology Clinical Trials Unit

    RECRUITING

    Adelaide, South Australia, 5000, Australia

  • Royal Prince Alfred Hospital

    RECRUITING

    Camperdown, New South Wales, 2050, Australia

  • Samsung Medical Center - PPDS

    RECRUITING

    Seoul, 06351, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

  • Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, 03722, South Korea

  • St. Vincent's Hospital Melbourne

    RECRUITING

    Melbourne, Victoria, 3065, Australia

  • Tel Aviv Sourasky Medical Center PPDS

    RECRUITING

    Tel Aviv, 6423906, Israel

  • The Alfred Hospital

    RECRUITING

    Prahan, Victoria, 3181, Australia

  • The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital)

    RECRUITING

    Seocho, 06591, South Korea

  • The Chaim Sheba Medical Center - PPDS

    RECRUITING

    Ramat Gan, Central District, 5262100, Israel

Conditions

Explore the condition pages connected to this study.

RELAPSED OR REFRACTORY MULTIPLE MYELOMA